C. Evan Ballantyne

2014 - Synthetic Biologics

In 2014, C. Evan Ballantyne earned a total compensation of $849.1K as Former Chief Financial Officer at Synthetic Biologics, a 116% increase compared to previous year.

Compensation breakdown

Bonus$150,000
Option Awards$355,950
Salary$324,068
Other$19,085
Total$849,103

Ballantyne received $356K in option awards, accounting for 42% of the total pay in 2014.

Ballantyne also received $150K in bonus, $324.1K in salary and $19.1K in other compensation.

Rankings

In 2014, C. Evan Ballantyne's compensation ranked 8,282nd out of 13,032 executives tracked by ExecPay. In other words, Ballantyne earned more than 36.4% of executives.

ClassificationRankingPercentile
All
8,282
out of 13,032
36th
Division
Manufacturing
3,071
out of 4,965
38th
Major group
Chemicals And Allied Products
1,042
out of 1,690
38th
Industry group
Drugs
821
out of 1,369
40th
Industry
Pharmaceutical Preparations
635
out of 1,042
39th
Source: SEC filing on July 6, 2016.

Ballantyne's colleagues

We found one more compensation record of an executive who worked with C. Evan Ballantyne at Synthetic Biologics in 2014.

2014

Jeffrey Riley

Synthetic Biologics

Chief Executive Officer

You may also like